DEUTSCHE BANK AG\

Bank

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in LCTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$240,154

+$161,539 QoQ

Shares Held

183,324

+4.9% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#30

of 130 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. LCTX ranks #229 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$240,154	183,324	+4.9%	Shares	Defined	2026-08-07
2025-03-31	$78,615	174,702	0.0%	Shares	Defined	2025-05-09
2024-12-31	$87,351	174,702	+196.0%	Shares	Defined	2025-06-30
2024-09-30	$53,717	59,030	+2.5%	Shares	Defined	2025-06-26
2024-06-30	$57,611	57,611	-23.1%	Shares	Defined	2025-06-12
2024-03-31	$110,850	74,899	-2.0%	Shares	Defined	2025-06-02
2023-12-31	$83,270	76,395	-3.4%	Shares	Defined	2024-02-14
2023-09-30	$93,330	79,094	+622.5%	Shares	Defined	2023-11-24
2023-06-30	$15,435	10,947	-83.9%	Shares	Defined	2023-08-14
2022-03-31	$104,850	68,085	-10.6%	Shares	Defined	2022-05-13
2021-12-31	$186,594	76,161	+5.6%	Shares	Defined	2022-02-16
2021-09-30	$181,780	72,135	+0.2%	Shares	Defined	2021-11-04
2021-06-30	$205,177	71,992	+113.8%	Shares	Defined	2021-08-11
2020-03-31	$27,954	33,680	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.